STAT+: After Eli Lilly granted one man special access to obesity drug, doctors struggle to get answers

Summary

Eli Lilly granted one patient early access to retatrutide, creating confusion among physicians about how to obtain the obesity drug for their own patients. Doctors are struggling to get clear guidance on access protocols for the investigational medication.